MB
MPM BioImpact LLC disclosed a 8.6% stake in CRBP
MPM BioImpact LLC reported owning 8.6% of Corbus Pharmaceuticals Holdings, Inc. (CRBP) (1,667,272 shares) in a Schedule 13G filed Nov 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 13, 2026
- Source
- Schedule 13G